Patent · US Active

Aminoimidazopyridazines

US9783543B2 · kind B2 · utility

0Cited by

4References

8Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Ludwig Zorn · Berlin, DE
Knut Eis · Berlin, DE
Volker Schulze · Hohen Neuendorf, DE
Detlev Sülzle · Berlin, DE
Florian Puehler · Wellesley, US
Philip Lienau · Berlin, DE
Ulf Bömer · Glienicke, DE
Kirstin Petersen · Berlin, DE
Andrea Hägebarth · Berlin, DE

Key dates

Filing date	Nov 14, 2013
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Nov 14, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I), in which A, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.